Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjie You

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Thoracic Disease|June 14, 2016
Pulmonary migratory infiltrates due to mycoplasma infection: case report and review of the literatureWenjie You, Bi Chen, Jing Li, et al.
Cell Insight|February 6, 2024
Elafibranor emerged as a potential chemotherapeutic drug for non-muscle invasive bladder cancerWang Wang, Danni Shan, Guanyi Wang, et al.
Cancer Cell International|October 29, 2020
Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMTRenjie Zhang, Zijian Wang, Wenjie You, et al.
International Journal of Oncology|February 25, 2022
High farnesoid X receptor expression predicts favorable clinical outcomes in PD‑L1<sup>low/negative</sup> non‑small cell lung cancer patients receiving anti‑PD‑1‑based chemo‑immunotherapyLina Wang, Xiaolong Xu, Bin Shang, et al.
International Immunopharmacology|February 2, 2021
Z-guggulsterone induces PD-L1 upregulation partly mediated by FXR, Akt and Erk1/2 signaling pathways in non-small cell lung cancerHan Tian, Yanni Gui, Yuanhui Wei, et al.
The Analyst|August 31, 2017
Integrating multiple fitting regression and Bayes decision for cancer diagnosis with transcriptomic data from tumor-educated blood plateletsGuangzao Huang, Mingshun Yuan, Moliang Chen, et al.
Frontiers in Immunology|March 23, 2023
Immune checkpoint inhibitor-associated toxicity in advanced non-small cell lung cancer: An updated understanding of risk factorsXiangxiao Hu, Lina Wang, Bin Shang, et al.
Cellular Signalling|January 22, 2026
NR4A1 attenuates neuroinflammation after spinal cord injury by modulating microglial polarization via negatively regulating the VAV1 pathwayNing Qu, WenJie You, LingLi Gong, et al.
Scientific Reports|July 2, 2025
SREBP-2 promotes cancer progression through the mevalonate-Akt pathway in non-small cell lung cancerWenjie You, Lili Su, Shuping Weng, et al.
Advanced Healthcare Materials|May 8, 2020
High Flexible and Broad Antibacterial Nanodressing Induces Complete Skin Repair with Angiogenic and Follicle RegenerationWeikang Hu, Zijian Wang, Yao Zha, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Thoracic Disease|June 14, 2016
Pulmonary migratory infiltrates due to mycoplasma infection: case report and review of the literatureWenjie You, Bi Chen, Jing Li, et al.
Cell Insight|February 6, 2024
Elafibranor emerged as a potential chemotherapeutic drug for non-muscle invasive bladder cancerWang Wang, Danni Shan, Guanyi Wang, et al.
Cancer Cell International|October 29, 2020
Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/AKT/mTOR signaling pathways and EMTRenjie Zhang, Zijian Wang, Wenjie You, et al.
International Journal of Oncology|February 25, 2022
High farnesoid X receptor expression predicts favorable clinical outcomes in PD‑L1<sup>low/negative</sup> non‑small cell lung cancer patients receiving anti‑PD‑1‑based chemo‑immunotherapyLina Wang, Xiaolong Xu, Bin Shang, et al.
International Immunopharmacology|February 2, 2021
Z-guggulsterone induces PD-L1 upregulation partly mediated by FXR, Akt and Erk1/2 signaling pathways in non-small cell lung cancerHan Tian, Yanni Gui, Yuanhui Wei, et al.
The Analyst|August 31, 2017
Integrating multiple fitting regression and Bayes decision for cancer diagnosis with transcriptomic data from tumor-educated blood plateletsGuangzao Huang, Mingshun Yuan, Moliang Chen, et al.
Frontiers in Immunology|March 23, 2023
Immune checkpoint inhibitor-associated toxicity in advanced non-small cell lung cancer: An updated understanding of risk factorsXiangxiao Hu, Lina Wang, Bin Shang, et al.
Cellular Signalling|January 22, 2026
NR4A1 attenuates neuroinflammation after spinal cord injury by modulating microglial polarization via negatively regulating the VAV1 pathwayNing Qu, WenJie You, LingLi Gong, et al.
Scientific Reports|July 2, 2025
SREBP-2 promotes cancer progression through the mevalonate-Akt pathway in non-small cell lung cancerWenjie You, Lili Su, Shuping Weng, et al.
Advanced Healthcare Materials|May 8, 2020
High Flexible and Broad Antibacterial Nanodressing Induces Complete Skin Repair with Angiogenic and Follicle RegenerationWeikang Hu, Zijian Wang, Yao Zha, et al.
Pageof 3